What are the differences between Type I (IgE‑mediated) hypersensitivity, Type II (tissue‑specific) hypersensitivity, Type III (immune‑complex‑mediated) hypersensitivity, and Type IV (cell‑mediated) hypersensitivity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Gell and Coombs Classification of Hypersensitivity Reactions

The four types of hypersensitivity reactions are distinguished by their underlying immune mechanisms, timing, and clinical manifestations, with Type I being IgE-mediated and immediate, Type II involving antibody-mediated cytotoxicity, Type III caused by immune complex deposition, and Type IV representing delayed T-cell-mediated responses 1.

Type I: IgE-Mediated Hypersensitivity

Mechanism:

  • IgE antibodies bind to mast cells and basophils
  • Re-exposure to antigen triggers immediate degranulation
  • Release of histamine, leukotrienes, and other inflammatory mediators

Timing: Occurs within minutes to hours (typically within 1-6 hours) 1

Clinical Examples:

  • Anaphylaxis (most severe manifestation)
  • Urticaria
  • Bronchospasm
  • Allergic rhinitis 1

Key Clinical Feature: These are immediate reactions that can be life-threatening, requiring prompt recognition and intramuscular adrenaline administration for anaphylaxis 1.

Type II: Antibody-Mediated Cytotoxic Reactions

Mechanism:

  • IgG or IgM antibodies directed against cell surface or tissue antigens
  • Leads to direct cellular destruction through complement activation or antibody-dependent cellular cytotoxicity

Clinical Examples:

  • Hemolytic anemia
  • Thrombocytopenia
  • Blood transfusion reactions 1

Distinguishing Feature: This type specifically targets and destroys cells or tissues, resulting in cytopenias or organ-specific damage 2.

Type III: Immune Complex-Mediated Hypersensitivity

Mechanism:

  • Formation of antigen-antibody immune complexes (IgG/IgM)
  • Deposition in tissues triggers complement activation
  • Recruitment of inflammatory cells causing tissue damage

Clinical Examples:

  • Serum sickness
  • Vasculitis 1

Key Characteristic: Involves circulating immune complexes that deposit in blood vessels and tissues, causing widespread inflammation rather than targeting specific cells 3.

Type IV: Delayed T-Cell-Mediated Hypersensitivity

Mechanism:

  • T lymphocyte-mediated response (not antibody-mediated)
  • Requires 24-72 hours for full manifestation
  • Can be further subdivided into four subtypes based on T-cell populations involved 2:

Subtypes:

  • Type IVa: CD4+ Th1-mediated with macrophage activation (granuloma formation)
  • Type IVb: CD4+ Th2-mediated with eosinophilic involvement (chronic asthma)
  • Type IVc: CD8+ cytotoxic T-cell-mediated (Stevens-Johnson syndrome, toxic epidermal necrolysis)
  • Type IVd: T-cell-driven neutrophilic inflammation (acute generalized exanthematous pustulosis)

Timing: Delayed onset, typically 24-72 hours or longer after exposure 1

Clinical Examples:

  • Allergic contact dermatitis
  • Maculopapular exanthema
  • Psoriasis
  • Erythema multiforme
  • Toxic epidermal necrolysis 1

Critical Clinical Distinctions

Timing is the primary differentiator:

  • Type I: Minutes to 6 hours (immediate)
  • Types II and III: Hours to days
  • Type IV: 24-72 hours to weeks (delayed) 1

Immune mediator:

  • Types I, II, III: Antibody-mediated (humoral immunity)
  • Type IV: Cell-mediated (T lymphocytes) 1

Common Pitfall: Many hypersensitivity diseases involve multiple reaction types simultaneously 4. For example, drug reactions may exhibit both immediate IgE-mediated features and delayed T-cell responses, requiring comprehensive evaluation rather than assuming a single mechanism.

Important Caveat: Not all adverse drug reactions are immune-mediated. Pseudoallergic reactions (anaphylactoid reactions) can mimic Type I reactions through direct mast cell degranulation without IgE involvement, such as cytokine-release syndrome 1. These require different diagnostic approaches and do not predict future reactions to structurally unrelated drugs.

References

2
Research

Chapter 28: Classification of hypersensitivity reactions.

Allergy and asthma proceedings, 2012

3
Research

Antibiotic Hypersensitivity Mechanisms.

Pharmacy (Basel, Switzerland), 2019

4
Research

Allergy: Type I, II, III, and IV.

Handbook of experimental pharmacology, 2022

Related Questions

Can you explain the immune mechanisms of the four types of hypersensitivity reactions and provide veterinary medicine examples for each?
Which antibiotics are known to cause adverse respiratory reactions such as wheezing, bronchospasm, cough, or dyspnea?
What is the recommended first‑line management for a 15‑month‑old boy with chronic rhinorrhea, cough, ear‑pulling, intermittent wheeze, underweight status, and suspected IgE‑mediated (type I) allergic hypersensitivity?
What are type 1 hypersensitivity reactions, including their mediators, clinical manifestations, and treatment strategies?
What is the appropriate timing for repeat serum IgE measurement to differentiate whether a female patient’s elevated IgE is due to true allergy or a post‑infectious rise, considering recent antibiotic treatment?
What are the functions of innate immunity, such as natural barriers and inflammation, compared to the functions of adaptive immunity, including humoral and cell‑mediated immunity?
Can Luftagastro (sodium alginate, potassium bicarbonate, calcium carbonate) replace Gaviscon for an adult with reflux‑related symptoms such as heartburn, acid regurgitation, or dyspepsia?
What is the recommended treatment for an acute cocaine-induced headache?
In a 67-year-old woman with insulin‑treated diabetes mellitus and no other known illnesses, what are the possible differential diagnoses for transient (≈30‑second) blurred vision and their approximate percentages?
Should a transvaginal ultrasound be obtained when polycystic ovary syndrome is not the only possible diagnosis for irregular menses?
Can electroconvulsive therapy be administered to a 57‑year‑old woman with a left ventricular ejection fraction of 20%?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.